Chemfab Alkalis Limited has submitted an investor presentation for the quarter ended December 31, 2025. The presentation, which is also available on the company's website (https://chemfabalkalis.com/), offers insights into the company's performance and strategic initiatives. During Q3FY26, global caustic prices remained soft, though ECU realization improved sequentially to ₹38,500 per MT from ₹36,700 per MT, supported by stronger chlorine realizations. Global caustic prices are perceived to have bottomed out, indicating potential for recovery. The Technology Modernisation Programme has been successfully completed with the new plant commissioned on December 30, 2025, expected to enhance operational efficiencies and volumes. The Captive Hybrid Power Plant is ready and anticipated to commence power supply from Q4FY26, promising significant cost savings. The OPVC segment experienced slower business under the Jal Jeevan Mission due to delayed fund flows, with demand revival expected after the upcoming budget. However, the company has grown OPVC volumes through projects outside the Jal Jeevan Mission. The consolidated performance is seen as having reached a trough, with gradual improvement expected in the coming quarters, driven by stabilizing realisations, modernized facilities, and hybrid power supply. The coming year is projected to be stronger for the OPVC business as demand normalizes. The company's financial highlights for Q3FY26 show a consolidated revenue from operations of ₹62.17 crore, with an operational EBITDA of ₹5.17 crore and an EBITDA margin of 8.32%. The Chlor-Alkali segment revenue was ₹47.52 crore with an operational EBITDA of ₹1.77 crore and a 3.72% margin. The OPVC segment revenue was ₹14.65 crore with an operational EBITDA of ₹3.40 crore and a 23.21% margin. Strategic initiatives include optimizing the Chlor-Alkali business through technology modernization (₹60 crore investment, expected completion July 2025) and investing in a hybrid power project. The OPVC Pipes business is undergoing rapid capacity expansion, scaling from 14,000 TPA in FY25 to 23,000 TPA in FY26, with plans for a potential Central India facility. The company continues to leverage its partnership with Molecor Tecnología S.L. for advanced manufacturing and aims for market penetration through government initiatives like Jal Jeevan Mission and AMRUT 2.0.
